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Professor JP Donnelly 
Editor-in-Chief 
Journal of Antimicrobial Chemotherapy 
 
Dear Professor Donnelly 
 
We are grateful for Professor Pulcini’s interest in our paper and for her comments highlighting the 
limitations of the use of Defined Daily Dosage (DDD) as a standardised measure of volume of 
antibiotic consumption. The data on which our analysis was based were derived from the European 
Centre of Disease Control which currently uses DDD to record antibiotic consumption. The data do 
not include information on duration of consumption. We acknowledge that DDDs have some 
limitations, particularly in relation to antibiotic consumption  in children. We note the evidence from 
McNeilly et al that a temporal rise in antibiotic volumes in Scotland was explained mainly by rising 
DDDs, and the report by Forst et al that DDDs overestimated prescribing volumes in German 
hospitals.(1,2)  
 
Professor Pulcini made the important observation that duration of treatment (DoT) may be 
independently associated with the development of antimicrobial resistance at a national level. It is 
likely that there are national differences in the conventions governing duration of antibiotic 
prescribing for different types of infection resulting in variation at national level in DoT. At present, 
we have no European data to monitor the role of DoT. These differences may explain some of the 
disparities we observed in our paper. In addition, consumption of antibiotics may be less 
predictable, and DDDs may be less reliable, as prescribers of antibiotics become less doctrinaire 
about the need to complete a course.(3)  
 
Future analysis of the association at national level between community antimicrobial consumption 
and resistance in invasive specimens should consider the role of duration of consumption.  
 
Yours sincerely 
 
 
 
 
Dr Lucy McDonnell 
Dr Mark Ashworth 
Professor David Armstrong 
Dr Alex Dregan 
Dr Umer Malik 
Dr Patrick White 
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